“Bringing Next Generation Immunotherapy to Cancer”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya SmaleLeave a Comment

John Maki of Vicus Therapeutics  joined us for World Orphan Drug Congress USA 2015 to present about ‘Bringing Next Generation Immunotherapy to Cancer’ .
Download the presentation now to learn more about:

  • Vicus’ next generation targets
  • First multi-pathway neuro-immune modulator for cancer
  • VT-122 pipeline in a product (today) 
  • VT-122 pipeline in a product (2018)
…and much more!
Get your copy here!
To find out more about  Vicus Therapeutics’ next generation immunotherapy , join us at  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment